Chemopreventive effects of Khaya senegalensis bark extract on human colorectal cancer

Anticancer Research

Volumn 26, Issue 3 B, 2006, Pages 2397-2405

  Androulakis, Xiao M ^a   Muga, Stephanie J ^a   Chen, Feng ^b   Koita, Youssouf ^c   Toure, Boubacar ^d   Wargovich, Michael J ^a,e  

^a UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b CLEMSON UNIVERSITY   (United States)

^c Ministry of Public Health   (Guinea)

^d GARDIEM ^*  (Guinea)

^e South Carolina Cancer Center   (United States)

Author keywords

Caspase 3; Cell cycle; COX 2; Khaya senegalensis; PGE2

Indexed keywords

CYCLOOXYGENASE 2 INHIBITOR; KHAYA SENEGALENSIS EXTRACT; PHENOL; PLANT EXTRACT; PROSTAGLANDIN E2; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; CARCINOMA CELL; CELL GROWTH; CELL STRAIN HT29; COLON CARCINOMA; COLORECTAL CANCER; ENZYME LINKED IMMUNOSORBENT ASSAY; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; WESTERN BLOTTING;

ANTIOXIDANTS; APOPTOSIS; CELL CYCLE; CELL GROWTH PROCESSES; COLORECTAL NEOPLASMS; CYCLIN D1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; DINOPROSTONE; FREE RADICAL SCAVENGERS; HT29 CELLS; HUMANS; MELIACEAE; PLANT BARK; PLANT EXTRACTS; PPAR GAMMA;

EID: 33745559401     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A, Feuer EJ and Thun MJ: Cancer statistics. CA Cancer J Clin 55: 10-30, 2005.
2. Bertagnolli MM: The potential of non-steroidal anti-inflammatory drugs (NSAIDs) for colorectal cancer prevention. J Surg Oncol 84: 113-119, 2003.
3. Huls G, Koornstra JJ and Kleibeuker JH: Non-steroidal anti-inflammatory drugs and molecular carcinogenesis of colorectal carcinomas. Lancet 362: 230-232, 2003.
4. Zha S, Yegnasubramanian V, Nelson WG, Isaacs WB and De Marzo AM: Cyclooxygenases in cancer: progress and perspective. Cancer Lett 215: 1-20, 2004.
5. Hawk ET, Umar A and Viner JL: Colorectal cancer chemoprevention - an overview of the science. Gastroenterology 126: 1423-1447, 2004.
6. Dubois RN and Marnett LJ: COX-2: A target for colon cancer prevention. Annu Rev Phamacol Toxicol 42: 55-80, 2002.
7. Chung YC, Chang CT, Chao WW, Lin CF and Chou ST: Antioxidative activity and safety of the 50 ethanolic extract from red bean fermented by Bacillus subtilis IMR-NK1. J Agric Food Chem 50: 2454-2458, 2002.
8. Parejo I, Viladomat F, Bastida J, Rosas-Romero A, Flerlage N, Burillo J and Codina C: Comparison between the radical scavenging activity and antioxidant activity of six distilled and nondistilled Mediterranean herbs and aromatic plants. J Agric Food Chem 50: 6882-6890, 2002.
9. Peng G, Wargovich MJ and Dixson DA: Anti-proliferative effects of green tea polyphenol EGCG on Ha-Ras-induced transformation of intestinal epithelial cells. Cancer Letters, in press, 2006.
10. Iwu MM: Handbook of African Medicinal Plants. Boca Raton, FL: CRC Press Inc., pp. 197, 1993
11. El Tahir A, Satti GM and Khalid SA: Antiplasmodial activity of selected Sudanese medicinal plants with emphasis on Maytenus senegalensis (Lam.) Exell. J Ethnopharmacol 64: 227-233, 1999.
12. El said F, Sofowora A and Olaniyi AA: Proceedings of Symposium on Inter-African Pharmacopoeia Traditional and Medicinal Plants. Dakar, pp. 246, 1968.
13. Sheng H, Shao J, Kirkland SC, Isakson P, Coffey RJ, Morrow J, Beauchamp RD and DuBois RN: Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2. J Clin Invest 99: 2254-2259, 1997.
14. Smith WL, DeWitt DL and Garavito RM: Cyclooxygenases: structural, cellular, and molecular biology. Annu Rev Biochem 69: 145-182, 2000.
15. Tsujii M and DuBois RN: Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell 83: 493-501, 1995.
16. Chulada PC, Thompson MB, Mahler JF, Doyle CM, Gaul BW, Lee C, Tiano HF, Morham SG, Smithies O and Langenbach R: Genetic disruption of Ptgs-1, as well as Ptgs-2, reduces intestinal tumorigenesis in Min mice. Cancer Res 60: 4705-4708, 2000.
17. Li M, Wu X and Xu XC: Induction of apoptosis in colon cancer cells by cyclooxygenase-2 inhibitor NS398 through a cytochrome c-dependent pathway. Clin Cancer Res 7: 1010-1016, 2001.
18. Uefuji K, Ichikura T, Shinomiya N and Mochizuki H: Induction of apoptosis by JTE-522, a specific cyclooxygenase-2 inhibitor, in human gastric cancer cell lines. Anticancer Res 20: 4279-4284, 2000.
19. Zhang X, Morham SG, Langenbach R and Young DA: Malignant transformation and antineoplastic actions of nonsteroidal antiinflammatory drugs (NSAIDs) on cyclooxygenase-null embryo fibroblasts. J Exp Med 190: 451-459, 1999.
20. Piazza GA, Rahm AL, Krutzsch M, Sperl G, Paranka NS, Gross PH, Brendel K, Burt RW, Alberts DS and Pamukcu R: Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis. Cancer Res 55: 3110-3116, 1995.
21. Piazza GA, Alberts DS, Hixson LJ, Paranka NS, Li H, Finn T, Bogert C, Guillen JM, Brendel K, Gross PH, Sperl G and Ritchie J: Sulindac sulfone inhibits azoxymethane-induced colon carcinogenesis in rats without reducing prostaglandin levels. Cancer Res 57: 2909-2915, 1997.
22. Chapple KS, Cartwright EJ, Hawcroft G, Tisbury A, Bonifer C, Scott N, Windsor AC, Guillou PJ, Markham AF, Coletta PL and Hull MA: Localization of cyclooxygenase-2 in human sporadic colorectal adenomas. Am J Pathol. 156: 545-553, 2000.
23. Roberts-Thomson SJ: Peroxisome proliferator-activated receptors in tumorigenesis: targets of tumour promotion and treatment. Immunol Cell Biol 78: 436-441, 2000.
24. Koeffler HP: Peroxisome proliferator-activated receptor gamma and cancers. Clin Cancer Res 9: 1-9, 2003.
25. Fisher DE: Apoptosis in cancer therapy: crossing the threshold. Cell 78: 539-542, 1994.
26. Lotem J and Sachs L: Regulation by Bcl-2, c-myc and p53 of susceptibility to induction of apoptosis by heat shcck and cancer chemotherapy compounds in differentiation-competent and defective myeloid leukemia cells. Cell Growth Different 4: 41-47, 1993.
27. Thioune O, Diallo AK, Diop AB, Ngom S and Lo I: Fractionation of the total extract of Khaya senegalensis barks. Interest in the formulation of an anti-inflammatory ointment Dakar Med 48: 68-71, 2003.